These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 716322)
21. [Acetylation processes in chronic alcoholics]. Kovalev IE; Kovalev EN; Seleznev NG Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211 [TBL] [Abstract][Full Text] [Related]
22. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381 [TBL] [Abstract][Full Text] [Related]
23. N-acetylation phenotyping with sulfamethazine in an Iranian population. Sardaş S; Lahijany B; Cok I; Karakaya AE Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437 [TBL] [Abstract][Full Text] [Related]
24. Hepatic acetylator phenotype in bladder cancer patients. Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447 [TBL] [Abstract][Full Text] [Related]
25. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
26. [Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls]. Sone M Hinyokika Kiyo; 1986 Aug; 32(8):1085-92. PubMed ID: 3788733 [TBL] [Abstract][Full Text] [Related]
28. Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation. Vas A; Gachályi B; Káldor A Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):111-4. PubMed ID: 2318546 [TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690 [TBL] [Abstract][Full Text] [Related]
30. An assessment of acetylator polymorphism and its relevance in Papua New Guinea. Hombhanje F P N G Med J; 1990 Jun; 33(2):107-10. PubMed ID: 2238823 [TBL] [Abstract][Full Text] [Related]
31. Caffeine as a potential indicator for acetylator status. Rankin RB; Hudson SA; Fell AF J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563 [TBL] [Abstract][Full Text] [Related]
32. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers. Augustynowicz-Kopeć E; Zwolska Z Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770 [TBL] [Abstract][Full Text] [Related]
33. Activity of N-acetyltransferase in patients with malignant lymphomas. Chekharina YeA ; Bulovskaya LN; Pavlova MV; Krupkin RG Neoplasma; 1978; 25(4):471-5. PubMed ID: 692806 [TBL] [Abstract][Full Text] [Related]
34. [Type of acetylation in children with Hodgkin's disease]. Kolygin BA; Bulovskaia LN; Nevolin-Lopatin AM; Safonova SA Vopr Onkol; 1986; 32(4):52-7. PubMed ID: 3705528 [TBL] [Abstract][Full Text] [Related]
35. [N-acetyltransferase activity during growth of the transplantable Pliss lymphosarcoma and during pregnancy in rats]. Riazanov EM; Aleksandrov VA; Bulovskaia AN Biull Eksp Biol Med; 1984 Jul; 98(7):68-70. PubMed ID: 6547867 [TBL] [Abstract][Full Text] [Related]
36. Characterization of arylamine acetyltransferase in the rabbit eye. Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333 [TBL] [Abstract][Full Text] [Related]
38. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. Bluhm RE; Adedoyin A; McCarver DG; Branch RA Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665 [TBL] [Abstract][Full Text] [Related]
39. Effect of physical training on sulfamethazine acetylation rate. Abzalov RA; Nigmatullina RR; Khairullina GN; Garmonov SY; Shakirova LS; Evgen'ev MI Bull Exp Biol Med; 2000 Dec; 130(12):1141-3. PubMed ID: 11276304 [TBL] [Abstract][Full Text] [Related]
40. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Andres HH; Weber WW Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]